EHMT2 and breast cancer: Together, the gene ontology results with the validation of survival and cell cycle genes suggest that HIF upregulation and the newly acquired sensitivity of target genes to the HIFs when derepressed by G9A inhibition may trigger a survival response in the breast cancer cells examined.